BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26842864)

  • 1. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
    Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
    Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy.
    Pereira JA; Gerber J; Ghidinelli M; Gerber D; Tortola L; Ommer A; Bachofner S; Santarella F; Tinelli E; Lin S; Rüegg MA; Kopf M; Toyka KV; Suter U
    Hum Mol Genet; 2020 May; 29(8):1253-1273. PubMed ID: 32129442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.
    Chen S; Huang P; Qiu Y; Zhou Q; Li X; Zhu M; Hong D
    Neuropathology; 2018 Feb; 38(1):34-40. PubMed ID: 28971531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
    Liewluck T; Lovell TL; Bite AV; Engel AG
    Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.
    Zhao M; Maani N; Dowling JJ
    Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two dynamin-2 genes are required for normal zebrafish development.
    Gibbs EM; Davidson AE; Trickey-Glassman A; Backus C; Hong Y; Sakowski SA; Dowling JJ; Feldman EL
    PLoS One; 2013; 8(2):e55888. PubMed ID: 23418470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
    Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
    Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
    Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
    Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease.
    Fabrizi GM; Ferrarini M; Cavallaro T; Cabrini I; Cerini R; Bertolasi L; Rizzuto N
    Neurology; 2007 Jul; 69(3):291-5. PubMed ID: 17636067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
    Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P
    Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in DNM2 gene in a large Italian family.
    Lopergolo D; Bocci S; Pinto AM; Valentino F; Doddato G; Ginanneschi F; Volpi N; Renieri A; Giannini F
    Neurol Sci; 2021 Jun; 42(6):2509-2513. PubMed ID: 33459893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.